Form 8-K - Current report:
SEC Accession No. 0001493152-26-000358
Filing Date
2026-01-05
Accepted
2026-01-05 15:43:27
Documents
13
Period of Report
2025-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41804
2 EX-10.1 ex10-1.htm EX-10.1 33002
  Complete submission text file 0001493152-26-000358.txt   251184

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE curx-20251231.xsd EX-101.SCH 3029
4 XBRL LABEL FILE curx-20251231_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE curx-20251231_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3377
Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753
Business Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 718-673-6078
Curanex Pharmaceuticals Inc (Filer) CIK: 0002025942 (see all company filings)

EIN.: 830741390 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42815 | Film No.: 26505611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)